0000920465-20-000018.txt : 20200116
0000920465-20-000018.hdr.sgml : 20200116
20200116160522
ACCESSION NUMBER: 0000920465-20-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200114
FILED AS OF DATE: 20200116
DATE AS OF CHANGE: 20200116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wellinghoff Darryl
CENTRAL INDEX KEY: 0001770350
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 20530974
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_157920870416334.xml
FORM 4
X0306
4
2020-01-14
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001770350
Wellinghoff Darryl
C/O LA JOLLA PHARMACEUTICAL COMPANY
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
0
1
0
0
Chief Commercial Officer
Common Stock
2020-01-14
4
P
0
3000
8.2255
A
6545
D
/s/ Ryan Murr, as attorney-in-fact for Darryl Wellinghoff
2020-01-16